Clinical trial
The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes…
NCT00313742 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00313742 |
|---|---|
| Title | The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins |
| Official title | An Assessment of the Impact of Performing Physical Exercise on the Maximum Plasma Glucose Decline in Subjects With Type 1 Diabetes Managed on a Basal Bolus Insulin Regimen: A Comparison of 3 Basal Insulin Treatments - Insulin Detemir, Insulin Glargine and NPH Insulin |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin detemir, insulin glargine, insulin NPH |
| Enrollment | 51 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Apr 12, 2006 |
| Last update posted | Nov 2, 2023 |
| Countries | Germany, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: